LinkedIn automations are now retired. TexAu V3 is on the way, be the first to know when it launches.

Get updates

How Much Did Color Raise? Headquarters, Funding & Key Investors

Color, a Burlingame-based virtual health and genomics company, has raised $491 million across multiple rounds, reaching a $4.6 billion valuation in November 2021. T. Rowe Price, General Catalyst, and Viking Global Investors led its latest $100 million Series E round in October 2021. Earlier rounds included a $167 million Series D (2020) and a $75 million Series D (2020). Founded in 2013 by Elad Gil, Othman Laraki, Nish Bhat, and Taylor Sittler, Color delivers AI-supported cancer prevention, diagnosis, and care solutions through its virtual clinic platform.

    Color is transforming oncology care through its end-to-end virtual clinic platform, offering cancer prevention, screening, and post-diagnosis support. The company integrates precision genomics, AI-based risk assessment, and personalized treatment guidance to make preventive healthcare more accessible. With a team of oncologists, genetic counselors, and care advocates, Color works closely with employers, health systems, and insurers to expand early detection and coordinated cancer care. Its platform empowers patients with timely insights and clinical support across the entire care continuum.

    What Is Color and What Does It Do?

    Color, founded in 2013 by Elad Gil, Othman Laraki, Nish Bhat, and Taylor Sittler, is a Burlingame-based (United States) virtual healthcare and genomics company. 

    Color employs 687 people and offers a virtual oncology platform that integrates AI, genomics, and clinical care to assess cancer risk, accelerate diagnosis, and support survivors. Its in-house team, comprising oncologists, genetic counselors, and care coordinators, provides direct patient support and personalized care pathways. 

    Color also partners with health plans and employers to make precision medicine accessible through scalable, tech-driven clinical programs.

    How Much Funding Has Color Raised?

    1. Series E

      Amount Raised: $100M
      Date: October 2021
      Lead Investors: Kindred Ventures, T. Rowe Price, General Catalyst, Viking Global Investors, Emerson Collective
      Motivation: To expand its virtual oncology platform and enhance partnerships with healthcare systems and payers.

    2. Series D
      Amount Raised: $167M
      Date: December 2020
      Lead Investors: General Catalyst, Viking Global Investors
      Motivation: To scale AI-enabled diagnostic capabilities and accelerate adoption of its virtual care platform.

    3. Series D
      Amount Raised: $75M
      Date: January 2020
      Lead Investors: Viking Global Investors, T. Rowe Price
      Motivation: To build out genomic infrastructure and expand its clinical care offerings.

    Total Funding Raised: $491 Million

    Current Valuation: $4.6 Billion (as of November 2021)

    Latest Funding Date: October 2021

    Key Investors

    1. T. Rowe Price
      Details: A leading global investment management firm providing growth-stage funding to innovative technology and healthcare companies.
      Investment Focus Areas: Healthcare innovation, fintech, and enterprise technology.
      Notable Investments: Color, Moderna, and Robinhood.
    2. General Catalyst
      Details: A venture capital firm supporting companies that transform industries through technology and human-centered design.
      Investment Focus Areas: Healthtech, AI, and enterprise software.
      Notable Investments: AirBnB, Livongo, and Stripe.
    3. Viking Global Investors
      Details: A Connecticut-based global investment firm investing across public and private markets.
      Investment Focus Areas: Healthcare, life sciences, and data analytics.
      Notable Investments: Color, Tempus, and Moderna.
    4. Emerson Collective
      Details: A social impact organization founded by Laurene Powell Jobs, focused on education, health, and innovation.
      Investment Focus Areas: Healthcare, biotech, and environmental innovation.
      Notable Investments: Color, Guild Education, and Andela.

    Where Is Color’s Headquarters?

    Color is headquartered in Burlingame, California, United States, strategically positioned in the Bay Area’s healthcare and biotech ecosystem. This location gives the company access to world-class research institutions, genomic technology talent, and healthcare innovation networks that support its mission to make precision oncology more accessible.

    What’s Next for Color?

    Color plans to broaden its AI-enabled oncology and preventive health programs, expanding partnerships with employers, health plans, and state governments. The company aims to integrate genomic insights with real-time care delivery, bridging the gap between early detection and clinical intervention. As cancer prevention becomes central to employer and payer strategies, Color is poised to lead the next phase of personalized, accessible, and tech-enabled cancer care worldwide.

    Get Investor & Funding Insights with TexAu 

    TexAu helps sales and business teams uncover detailed fundraising information on companies like Color. Use the platform to research investors, track funding rounds, and gather actionable insights to strengthen prospecting and business strategy.

    Sign Up for Free on TexAu and start uncovering detailed funding insights that give your business a competitive edge.

    Start your 14-day free trial today, no card needed

    TexAu updates, tips and blogs delivered straight to your inbox.